Quantcast
High-Dose Flu Vaccine More Effective In Elderly

High-Dose Flu Vaccine More Effective In Elderly, Vanderbilt-Led Study Shows

Craig Boerner, Vanderbilt University High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications, according to a Vanderbilt-led...

Latest Flu season Stories

2014-08-18 04:21:18

CYPRESS, Calif. and LONDON, Aug. 18, 2014 /PRNewswire-iReach/ -- Immune Targeting Systems (ITS), specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (Flunisyn(TM)) designed to protect humans from all strains of seasonal and pandemic influenza A. To determine the effectiveness of Flunisyn(TM) ITS produced its own live influenza challenge agent derived from the recently circulating Influenza A/California/2009 (H1N1)...

2014-07-29 23:09:40

The National Foundation for Infectious Diseases (NFID) has been named a 2014 ASAE Power of A Silver Award winner for 'Keeping the Nation Flu-Focused,' a public awareness campaign to encourage everyone age six months and older to be vaccinated against influenza annually. Bethesda, Maryland (PRWEB) July 29, 2014 The National Foundation for Infectious Diseases (NFID) has been named a 2014 ASAE Power of A Silver Award winner for "Keeping the Nation Flu-Focused," a public...

2014-07-02 16:24:52

-- The Novartis influenza vaccine portfolio in the US includes Flucelvax® and Fluvirin® CAMBRIDGE, Mass., July 2, 2014 /PRNewswire/ -- Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2014-2015 season. Novartis plans to ship a minimum of 30 million doses of vaccines (Flucelvax(®) [Influenza Virus Vaccine] and Fluvirin(® )[Influenza Virus Vaccine]) to the US market in advance of the peak of influenza season....

2014-06-18 08:29:32

TITUSVILLE, New Jersey, June 18, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (Janssen) announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A. VX-787 is an investigational medicine designed to directly inhibit replication of the influenza A virus, including recent H1...

2014-06-16 08:29:05

First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes WALTHAM, Mass., June 16, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Alere(TM) i Influenza A & B test, the first and only molecular test to detect and differentiate influenza A and B virus in less...

Modern Bird Genes Have Potential To Cause A Pandemic Similar To 1918 Spanish Flu
2014-06-12 10:02:18

Lawrence LeBlond for redOrbit.com - Your Universe Online Avian bird flu strains that exist today share very similar characteristics with the deadly 1918 Spanish Flu strain that killed nearly five percent of the world’s population. That flu virus pandemic was the worst outbreak ever recorded and new research has found that only a few amino acids separate viral proteins currently found in bird populations from those that existed during the 1918 virus. The new evidence suggests a similar...

2014-05-06 04:22:59

High level of vaccination, and low level of flu, among seniors NEW YORK, May 6, 2014 /PRNewswire/ -- Last winter's flu season was fairly typical of other winters over the last decade, with the prevalence of the flu and the number of people who had flu shots both fairly close to the averages for that time period. The effectiveness of flu vaccines also seems to have been fairly typical. http://photos.prnewswire.com/prnvar/20100517/NY06256LOGO These are some of the results of The Harris Poll of...

2014-04-29 23:03:36

The National Foundation for Infectious Diseases (NFID) has been selected as the Honorable Mention recipient of the 2014 National Adult and Influenza Immunization Summit (NAIIS) Immunization Excellence Award for Overall Flu Season Activities. Bethesda, Maryland (PRWEB) April 29, 2014 The National Foundation for Infectious Diseases (NFID) has been selected as the Honorable Mention recipient of the 2014 National Adult and Influenza Immunization Summit (NAIIS) Immunization Excellence Award...

Mystery Of 1918 Pandemic Flu Virus Solved
2014-04-29 03:47:04

Daniel Stolte, University of Arizona University of Arizona researcher Michael Worobey and his team have discovered the key to understanding influenza pandemics may lie in previous flu exposure during childhood A study led by Michael Worobey at the University of Arizona in Tucson provides the most conclusive answers yet to two of the world's foremost biomedical mysteries of the past century: the origin of the 1918 pandemic flu virus and its unusual severity, which resulted in a death...

2014-04-28 12:31:40

Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries KING OF PRUSSIA, Pa., April 28, 2014 /PRNewswire/ -- bioCSL, formerly CSL Biotherapies, has announced the donation of more than 700,000 doses of its influenza vaccine to the Partnership for Influenza Vaccine Introduction, an innovative program - spearheaded by the U.S. Centers for Disease Control and Prevention (CDC) and the Task Force for...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related